- +112.8% price growth over the last year
- Lower volatility than the market (beta -0.20)
- Low bankruptcy risk (Altman Z-Score: 39.34)
Green day on Friday for Amylyx Pharmaceuticals, Inc.
(Updated on Jul 17, 2026)
The Amylyx Pharmaceuticals, Inc. stock price gained 4.29% on the last trading day (Friday, 17th Jul 2026), rising from $17.02 to $17.75. During the last trading day the stock fluctuated 9.05% from a day low at $16.57 to a day high of $18.07. The price has fallen in 6 of the last 10 days and is down by -2.85% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 283 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $21.74 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.20% during the next 3 months and, with a 90% probability hold a price between $15.83 and $21.48 at the end of this 3-month period.
AMLX Signals & Forecast
The Amylyx Pharmaceuticals, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $17.76. On a fall, the stock will find some support from the long-term average at approximately $16.07. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -5.08%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Amylyx Pharmaceuticals, Inc. stock
Amylyx Pharmaceuticals, Inc. finds support from accumulated volume at $17.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.50 between high and low, or 9.05%. For the last week, the stock has had daily average volatility of 6.69%.
Our recommended stop-loss: $16.91 (-4.71%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)
Trading Expectations (AMLX) For The Upcoming Trading Day Of Monday 20th
For the upcoming trading day on Monday, 20th we expect Amylyx Pharmaceuticals, Inc. to open at $17.46, and during the day (based on 14 day Average True Range), to move between $17.23 and $18.27, which gives a possible trading interval of +/-$1.04 (+/-6.03%) up or down from last closing price. If Amylyx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 6.03% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $17.79 (0.23%) than the support at $17.44 (1.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Amylyx Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amylyx Pharmaceuticals, Inc. stock to perform well in the short-term.
Current score:
1.292
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 20, 2026 - $17.46 ( 1.62%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AMLX Performance
Trading levels for AMLX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 18.96 | 6.84% |
| R2 | 18.39 | 3.61% |
| R1 | 18.04 | 1.61% |
| Price | 17.75 | |
| S1 | 16.89 | -4.84% |
| S2 | 16.54 | -6.84% |
| S3 | 15.96 | -10.07% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 18.70 | 5.35% |
| R2 | 17.96 | 1.18% |
| R1 | 17.79 | 0.225% |
| Price | 17.75 | |
| S1 | 17.44 | -1.75% |
| S2 | 15.19 | -14.42% |
| S3 | 14.31 | -19.38% |
AMLX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jan 25, 2018 | Mar 28, 2018 | Apr 02, 2018 | $0.420 | 0% |
| 2 | Dec 28, 2017 | Dec 28, 2017 | Jan 02, 2018 | $0.360 | 0% |
| 3 | Sep 28, 2017 | Sep 28, 2017 | Oct 02, 2017 | $0.240 | 0% |
FAQ
Click here for our free guide on how to buy Amylyx Pharmaceuticals, Inc. Stock.
Buy AMLX